Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

BACKGROUND: Upregulated expression and aberrant activation of the epidermal growth-factor receptor (EGFR) are found in lung cancer, making EGFR a relevant target for non-small-cell lung cancer (NSCLC). Treatment with anti-EGFR monoclonal antibodies (mAbs) is associated with modest improvement in ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonomi, P D, Gandara, D, Hirsch, F R, Kerr, K M, Obasaju, C, Paz-Ares, L, Bellomo, C, Bradley, J D, Bunn Jr, P A, Culligan, M, Jett, J R, Kim, E S, Langer, C J, Natale, R B, Novello, S, Pérol, M, Ramalingam, S S, Reck, M, Reynolds, C H, Smit, E F, Socinski, M A, Spigel, D R, Vansteenkiste, J F, Wakelee, H, Thatcher, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128180/
https://www.ncbi.nlm.nih.gov/pubmed/29905778
http://dx.doi.org/10.1093/annonc/mdy196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128180/
https://www.ncbi.nlm.nih.gov/pubmed/29905778
http://dx.doi.org/10.1093/annonc/mdy196

Ejemplares similares